Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): A California Cancer Registry analysis

被引:54
作者
Lara, Matthew S. [1 ]
Brunson, Ann [2 ,3 ]
Wun, Ted [2 ,3 ]
Tomlinson, Ben [2 ,3 ]
Qi, Lihong [2 ,3 ,4 ]
Cress, Rosemary [2 ,3 ,4 ]
Gandara, David R. [2 ,3 ]
Kelly, Karen [2 ,3 ]
机构
[1] Davis Senior High Sch, Davis, CA USA
[2] Univ Calif Davis, Sch Med, Div Hematol Oncol, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Ctr Comprehens Canc, Sch Med, Sacramento, CA 95817 USA
[4] UC Davis Sch Med, DC Davis Dept Publ Hlth Sci, Davis, CA USA
关键词
Non-small cell lung cancer; Young patients; Cause specific survival; Registry analysis; Epidemiology; Prognosis; EPIDEMIOLOGY; SURVEILLANCE; TRENDS; OLD;
D O I
10.1016/j.lungcan.2014.04.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Non-small cell lung cancer (NSCLC) is uncommonly diagnosed in patients younger than 50 years of age. We analyzed the California Cancer Registry (CCR) to describe epidemiologic characteristics and outcomes in this patient subset and to identify factors prognostic for cause-specific survival (CSS). Methods: Patients diagnosed with NSCLC between 1/1/98 through 12/31/09 and reported to the (CCR) as of October 2011 were included. The primary outcome measure was CSS. Cox regression models were used to evaluate predictors of CSS in young patients with NSCLC, adjusted for potential confounders. Interaction analysis was performed between age groups (<50 vs. >= 50) and specific demographic and tumor covariates. Results: We identified 132,671 lung cancer cases, of which 114,451 (86.3%) had NSCLC. Of these, 6389 (5.6%) were <50 years of age (median, 46 years). The most common histology was adenocarcinoma (3697, 57.9%). Most patients had stage III (1522, 23.8%) or IV (3655, 57.2%) disease. Fewer young patients were diagnosed in recent years (n, % of total NSCLC population of that era): 1998-2001 (2355, 6.0), 2002-2005 (2182, 5.7), and 2006-2009 (1852, 5.0), P<0.001. Multivariate analysis showed that age <50 years was an independent predictor of improved CSS (HR 0.827, P<0.001). Significant predictors of better CSS in patients <50 years included female sex, Asian or Hispanic ethnicity, lower stage, later year of diagnosis, and higher socioeconomic status, among others. Adenocarcinoma histology was not associated with improved CSS in this patient subset (HR 0.987, P=0.78). Interaction analysis revealed that Hispanic race and bronchioloalveolar histology had differential CSS outcomes dependent on age group. Conclusions: This large registry study found that age <50 years is an independent predictor of improved CSS. Variables prognostic for CSS differed somewhat from those in older patients. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 50 条
  • [31] Predictive Role of Tumor-Stroma Ratio for Survival of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis
    Zhang, Xuefeng
    Ma, Hongfu
    Zhang, Liang
    Li, Fenghuan
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 27
  • [32] Surgery or radiotherapy improves survival in elderly patients with early non-small cell lung cancer: A population-based analysis
    Shi, Pingfan
    Li, Ziye
    Zhang, Yanfei
    Shen, Changxing
    Xia, Qing
    Cao, Chuanwu
    Li, Ming
    Fan, Lihong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (04) : 1251 - 1257
  • [33] Proteomic biomarkers of non-small cell lung cancer patients
    Baran, Kamila
    Brzezianska-Lasota, Ewa
    ADVANCES IN RESPIRATORY MEDICINE, 2021, 89 (04) : 419 - 426
  • [34] Spirometry at diagnosis and overall survival in non-small cell lung cancer patients
    Zhai, Ting
    Li, Yi
    Brown, Robert
    Lanuti, Michael
    Gainor, Justin F.
    Christiani, David C.
    CANCER MEDICINE, 2022, 11 (24): : 4796 - 4805
  • [35] Clinicopathological characteristics and prognosis of young patients aged=45 years old with non-small cell lung cancer
    Xia, Jingjing
    Li, Hong
    Zhang, Ruirui
    Wang, Jipeng
    OPEN MEDICINE, 2023, 18 (01):
  • [36] Progress in Standard of Care Therapy and Modest Survival Benefits in the Treatment of Non-small Cell Lung Cancer Patients in the Netherlands in the Last 20 Years
    van der Drift, Miep A.
    Karim-Kos, Henrike E.
    Siesling, Sabine
    Groen, Harry J. M.
    Wouters, Michel W. J. M.
    Coebergh, Jan-Willem
    de Vries, Esther
    Janssen-Heijnen, Maryska L. G.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (02) : 291 - 298
  • [37] Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer
    Onal, Ozgur
    Kocer, Murat
    Eroglu, Hande Nur
    Yilmaz, Servet Derya
    Eroglu, Ismet
    Karadogan, Dilek
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (08) : 1838 - 1850
  • [38] A retrospective comparative analysis of elderly and younger patients undergoing pulmonary resection for stage I non-small cell lung cancer
    Park, Byungjoon
    Lee, Genehee
    Kim, Hong Kwan
    Choi, Yong Soo
    Zo, Jae Il
    Shim, Young Mog
    Kim, Jhingook
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [39] Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
    Aguiar, Filipa
    Fernandes, Gabriela
    Queiroga, Henrique
    Machado, Jose Carlos
    Cirnes, Luis
    Moura, Conceicao Souto
    Hespanhol, Venceslau
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (01): : 10 - 17
  • [40] Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger Patients
    Goodgame, Boone
    Viswanathan, Avinash
    Zoole, Jennifer
    Gao, Feng
    Miller, C. Ryan
    Subramanian, Janakiraman
    Meyers, Bryan F.
    Patterson, Alexander G.
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) : 1370 - 1374